Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | KMO | O15229 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.39 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.39 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.39 |
| ▸ | CUL4A | Q13619 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CRHBP | P24387 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7383122 | 0.92 | KMT2A (0.45) | KMT2AMEN1CYP2C19ALDH1A1SMN1; SMN2 | |
| SCHEMBL3724640 | 0.92 | SMN1; SMN2 (0.47) | KMT2AMEN1CYP2C19ALDH1A1SMN1; SMN2 | |
| SCHEMBL11450688 | 0.86 | CYP2C19 (0.40) | KMT2AMEN1CYP2C19ALDH1A1SMN1; SMN2 | |
| SCHEMBL9817222 | 0.86 | CYP2C19 (0.59) | KMT2ACYP2C19ALDH1A1SMN1; SMN2HPGD | |
| SCHEMBL11450733 | 0.82 | KMT2A (0.50) | KMT2AMEN1CYP2C19ALDH1A1SMN1; SMN2 | |
| SCHEMBL7114768 | 0.81 | SMN1; SMN2 (0.47) | KMT2AMEN1CYP2C19ALDH1A1SMN1; SMN2 | |
| SCHEMBL11467472 | 0.79 | KMT2A (0.47) | KMT2AMEN1CYP2C19ALDH1A1SMN1; SMN2 | |
| SCHEMBL9755876 | 0.79 | ALDH1A1 (0.34) | KMT2AMEN1CYP2C19ALDH1A1HPGD | |
| SCHEMBL11450055 | 0.77 | TDP1 (0.37) | KMT2AMEN1ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL11450048 | 0.75 | ALDH1A1 (0.47) | KMT2AMEN1CYP2C19ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-57035574-A | — | — | None | — | — | JP | disclosed |
| US-20260137765-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | INSTITUT CURIE (FR) | 2026-05-21 | — | — | US | disclosed |
| US-20260108497-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICALC., LTD. (JP) | 2026-04-23 | — | — | US | disclosed |
| EP-4707284-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | Otsuka Pharmaceutical Co., Ltd. (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-12527854-B2 | Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof | INSTITUT CURIE (FR) | 2026-01-20 | — | — | US | disclosed |
| WO-2025089370-A1 | COMPOUNDS AS CSF1R INHIBITORS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-05-01 | — | — | WO | disclosed |
| US-20250051310-A1 | BENZAZEPINE DERIVATIVES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-02-13 | — | — | US | disclosed |
| WO-2024228399-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | 大塚製薬株式会社 | 2024-11-07 | — | — | WO | disclosed |
| US-20240286999-A1 | AZABICYCLO[3.1.0]HEXANE COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-08-29 | — | — | US | disclosed |
| US-20240148699-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2024-05-09 | — | — | US | disclosed |
| US-4191762-A | CEPHALOSPORIN BACTERICIDES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-03-04 | — | — | US | disclosed |
| US-4190448-A | ACRYLIC ACID POLYMER CROSSLINKED WITH POLYHYDRIC ALCOHOL IN PRESENCE OF CONDENSATION-TYPE CROSSLINKING AGENT | FUJI PHOTO FILM CO., LTD. (JP) | 1980-02-26 | — | — | US | disclosed |
| EP-0007594-A1 | Process for the preparation of high molecular-weight polyurethanes, soluble in organic solvents, from the usual reagents and in combination with bis-aminopropyl-polytetrahydrofuranes | BASF Aktiengesellschaft (DE) | 1980-02-06 | — | — | EP | disclosed |
| EP-0007470-A2 | Cephem compounds, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-02-06 | — | — | EP | disclosed |
| EP-0007633-A2 | Cephem compounds, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-02-06 | — | — | EP | disclosed |
| US-4181800-A | ANTIBIOTICS FROM SUBSTITUTED PERHYDRO-S-TRIAZINES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
| US-4172198-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-10-23 | — | — | US | disclosed |
| US-4152433-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-05-01 | — | — | US | disclosed |
| EP-0001125-A2 | Cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-03-21 | — | — | EP | disclosed |
| EP-0000644-A2 | Lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1979-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12527854-B2 | Methods of producing Shiga toxin B-subunit (STxB) monomers and oligomers, and uses thereof | STXBP1, RNGTT, UPF1 | KMT2A 1584/4885MEN1 1288/4885CYP2C19 4867/4885 |
| US-20240148699-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | PDE3B, PDE4A, PDE3A | KMT2A 2947/4885MEN1 1962/4885CYP2C19 31/4885 |
| US-20260108497-A1 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | PDE7B, PDE4B, PDE1B | KMT2A 3262/4885MEN1 2691/4885CYP2C19 33/4885 |
| US-20240286999-A1 | AZABICYCLO[3.1.0]HEXANE COMPOUND | MALT1, CXCR1, AZI2 | KMT2A 1209/4885MEN1 256/4885CYP2C19 510/4885 |
| US-20260137765-A1 | METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STXB) MONOMERS AND OLIGOMERS, AND USES THEREOF | STXBP1, HBB, UPF1 | KMT2A 1769/4885MEN1 1342/4885CYP2C19 4877/4885 |
| US-20250051310-A1 | BENZAZEPINE DERIVATIVES | AVPR2, AVPR1A, AVPR1B | KMT2A 701/4885MEN1 356/4885CYP2C19 362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.